Market Overview

Medtronic Narrows FY13 EPS Outlook

Share:
Related MDT
4 Biomedical Stocks Canaccord Loves
Medtronic plc: Medtronic Drug-Coated Balloon for Treatment of Peripheral Arterial Disease Shows Strong Results in Long Lesions
6 High Yield Dividend Aristocrat Dividend Increases In June (Seeking Alpha)

In a presentation to investors, Medtronic, Inc. (NYSE: MDT) today updated diluted earnings per share (EPS) guidance for fiscal year 2013.

The Company tightened its fiscal 2013 diluted EPS guidance range to $3.66 to $3.70 from the previously stated range of $3.62 to $3.70. The new range implies annual EPS growth of 6 to 7%.

Posted-In: News Guidance

 

Related Articles (MDT)

Around the Web, We're Loving...

Get Benzinga's Newsletters